Related Experiment Video
Updated: Jun 10, 2026

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients
E Luzi1, F Marini, I Tognarini
1Department of Internal Medicine, Metabolic Bone Unit, Regional Center for Hereditary Endocrine Tumors, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
Abstract:
Multiple endocrine neoplasia type 1 (MEN1) syndrome is characterized by the occurrence of tumors of parathyroids, neuroendocrine cells of the gastro-enteropancreatic tract and anterior pituitary. MEN1 gene encodes menin-oncosuppressor protein. Loss of heterozygosity at 11q13 is typical of MEN1 tumors. We have analyzed the MEN1 mRNA and menin expression in fibroblasts from normal skin biopsies and from MEN1 patients (two with a frameshift 738del4 (exon 3) mutation, introducing a premature stop codon, and an individual with an R460X (exon 10) nonsense mutation). The expression of full-length menin protein did not differ between MEN1 and normal fibroblasts. Wild-type alleles mRNAs were expressed in MEN1 patients, whereas mutant alleles were partially degraded by nonsense-mediated mRNA decay pathway, suggesting a mechanism of compensation for allelic loss by the up-regulation of wild-type menin expression at a post-transcriptional level. Small-interfering RNA silencing of the wild-type mRNA allele abolished menin compensation, whereas the ribozyme silencing of the MEN1-mutated mRNA allele resulted in strongly enhanced wild-type menin expression. Gel-retardation analysis showed that in vitro-specific RNA-protein complexes bound to MEN1 mRNA. These findings contribute to the understanding of tumorigenesis in MEN1, offering the basis for the development of RNA-based therapies in MEN1 gene mutation carriers.
Insights
Multiple endocrine neoplasia type 1 (MEN1) involves tumors due to MEN1 gene mutations. Wild-type MEN1 gene expression compensates for mutations post-transcriptionally, suggesting potential RNA-based therapies.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Multiple endocrine neoplasia type 1 (MEN1) syndrome is a genetic disorder characterized by tumors in parathyroid glands, gastroenteropancreatic neuroendocrine cells, and anterior pituitary.
- The MEN1 gene encodes the menin tumor suppressor protein, and loss of heterozygosity at 11q13 is a hallmark of MEN1-associated tumors.
Purpose of the Study:
- To investigate the expression of MEN1 mRNA and menin protein in fibroblasts from MEN1 patients with specific mutations.
- To elucidate the post-transcriptional regulatory mechanisms of MEN1 gene expression in the context of disease.
Main Methods:
- Analysis of MEN1 mRNA and menin protein expression in fibroblasts from normal individuals and MEN1 patients.
- Utilizing small-interfering RNA (siRNA) and ribozyme silencing to manipulate MEN1 alleles.
- Employing gel-retardation assays to study RNA-protein interactions.
Main Results:
- Full-length menin protein expression was comparable between MEN1 and normal fibroblasts.
- MEN1 patients showed expression of wild-type MEN1 alleles, with mutant alleles undergoing degradation via nonsense-mediated mRNA decay.
- Silencing wild-type MEN1 mRNA abolished compensation, while silencing mutant MEN1 mRNA enhanced wild-type expression, indicating post-transcriptional compensation.
Conclusions:
- MEN1 gene mutation carriers exhibit post-transcriptional upregulation of wild-type menin expression as a compensatory mechanism.
- These findings provide insights into MEN1 tumorigenesis and support the development of RNA-based therapeutic strategies for MEN1.
More Related Videos
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Ribozymes
Ribozymes can be...
Ribozymes
Ribozymes can be...